The Global Cell Analysis Market in terms of revenue was estimated to be worth $20.2 billion in 2023 and is poised to reach $33.9 billion by 2028, growing at a CAGR of 10.9% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Increase in the preference for cell-bsaed assays along with strong funding for cell-based research is expected to drive the market growth. The conventional methods of toxicity and drug safety assessment (involving animal testing) are expensive, time-consuming, and offer low-throughput. In this regard, modern cell-based assays merge the advantages of cell cultures and animal models to allow researchers to identify problems with lead compounds in early screening, ensuring greater efficiency in the drug discovery and development process.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157543946
Cell Analysis Market Dynamics
DRIVER: Growing number of drug discovery activities
Adoption of cell-based screening assays has increased in he drug discovery activities to understand associated complexities. Additionally, advances in cell biology, bioinformatics, molecular biology, genomics, and proteomics have generated large volumes of data, owing to which the use of cell-based assays in the drug development process has gained importance. Similarly, the Human Genome Project has generated a number of targets on which drug screening experiments can be carried out. This rapid expansion in drug targets and drug leads in recent years has accelerated the development of cell-based assays for primary and secondary screening in drug discovery.
RESTRAINT: High cost of instruments and restrictions on reagent use
The introduction of high-throughput screening (HTS) and high-content screening (HCS) technologies in cell analysis has increased their reliability. However, these technologies have also resulted in a significant increase in the cost of instruments. Moreover, the time and cost involved in each HTS process are directly proportional to the target molecule’s complexity; consequently, the higher the complexity, the greater the cost. In biopharmaceutical companies, the overall cost of production of biopharmaceuticals has increased considerably due to the use of these expensive systems.
OPPORTUNITY: Application of novel cell-based assays in cancer research
In the last few decades, the incidence and prevalence of cancer have increased significantly across the globe, and this trend is expected to continue in the coming years. In an effort to reduce cancer incidence and mortality, the demand for novel approaches that offer effective cancer diagnosis and treatment has increased in recent years. In this regard, some recent studies have been published that highlight the importance of cell-based assays in cancer research.
The software segment of the cell analysis industry is expected to grow at the highest rate during the forecast period
Based on product & service, the global cell analysis market is segmented into reagents & consumables, instruments, accessories, software, and services. The reagents & consumables segment accounted for the largest share of the market in 2022. Prominent companies are providing flow cytometry reagents as directly conjugated products. Companies are introducing high-quality reagents with an enhanced geographic reach contributing to the largest share of the reagents & consumables market. Innovative offerings addressing complex datasets with multiple analytical modalities for effective interpretation is the key contributing factor to the segment’s fastest growth.
Request 10% Customization:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=157543946
The flow cytometry technique dominated the cell analysis industry
Based on technique, the global cell analysis market is segmented into flow cytometry, PCR, cell microarrays, microscopy, spectrophotometry, high-content screening, and other techniques. The flow cytometry segment accounted for the largest market share in 2022. Increase in demand for flow cytometry in single-cell analysis studies to analyze multiple characteristics of the sample at single-cell level is the key driving factor of this segment. Additionally, high-content screening segment has registerd highest growth ratefrom 2023-2028, with high demand for HCS products in cell behavior studies.
The single-cell analysis segment of the cell analysis industry is expected to register the highest CAGR during the forecast period
Based on process, the global cell analysis market is segmented into cell identification, cell viability, cell signaling pathway/signal transduction, cell proliferation, cell counting & quality control, cell interaction, cell structure study, target identification & validation, and single-cell analysis. Cell identification accounted for the largest market share of in 2022. High adoption of cell identification products across industrial applications, including food and healthcare is a key contributing factor to the segment growth. Cell identification is crucial to drug discovery and high adoption of these products have propelled companies to introduce innovative products. On the other hand, single-cell analysis segment is expected to grow at the fastest pace during the forecast period. Single-cell analysis has gained significant traction over the years for assessment of individual cells at multi-parametric level, contributing to the segment growth.
The pharmaceutical & biotechnology companies accounted for the largest share in the cell analysis industry
Based on end user, the cell analysis market is segmented into pharmaceutical & biotechnology companies, hospitals & clinical testing laboratories, academic & research institutes, and other end users. The other end users are inclusive of forensic laboratories, blood banks, CROs, food & beverage manufacturers, and environmental monitoring organizations. The pharmaceutical & biotechnology companies segment accounted for the largest market share in 2022. Frequent adoption of consumables and instruments across different steps in drug discovery & development has led to the dominance of pharmaceutical & biotechnology end users. Additionally, hospitals and clinical testing laboratories segment is anticipated to grow at the fastest pace throughout the forecast period. Adoption of highly complex and specialized assays across this end user segment is expected to support its rapid growth.
North America was the largest regional market for cell analysis industry in 2022.
Geographically, the cell analysis market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region is expected to dominate the market through 2021-2028, followed by Europe. The US pharmaceutical industry has witnessed tremendous growth due to the increasing approval of first-in-class drugs by the Food and Drugs Administration (FDA), rising R&D expenditure by pharmaceutical companies, and the establishment of startups focusing on developing promising drugs for rare diseases and neurological conditions. This has propelled cell-based research activities, offering lucrative opportunities for the growth of the market in the US. Asia Pacific market is expected to grow at the fastest pace through 2023 to 2028.
Prominent Players:
Danaher (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), General Electric (US), Merck KGaA (US), Agilent Technologies (US), Olympus Corporation (Japan), Miltenyi Biotec (US), Bio-Rad Laboratories (US), BioStatus Limited (UK), Fluidigm Corporation (US), NanoCellect Biomedical (US), Cell Biolabs (US), Creative Bioarray (US), Meiji Techno (US), Promega Corporation (US), PerkinElmer (US), Tecan Trading AG (Switzerland), CELLINK (US), QIAGEN (Germany), Corning Incorporated (US), 10x Genomics (US), and Illumina (US).
Recent Developments of Cell Analysis Industry
- In 2023, Becton, Dickinson and Company (US) launched a Spectral Cell Sorter that is coupled with high-speed cell imaging. this product combines real-time imaging technology with spectral flow cytometry.
- In 2020, Miltenyi Biotec (Germany) launched MACS GMP Tyto Cartridge, a GMP-compliant cell sorter..
- In 2020, Bio-Rad Laboratories, Inc. (US) acquired Celsee, Inc., a provider of instruments and consumables for the isolation, detection, and analysis of single cells. This acquisition expanded the company’s product offerings in the flow cytometry market.
Cell Analysis Market Advantages:
- Comprehensive Understanding: Cell analysis techniques enable researchers to gain a comprehensive understanding of cellular behavior and function. By analyzing various cellular parameters, such as morphology, gene expression, protein levels, and metabolic activity, researchers can unravel complex biological processes and uncover underlying mechanisms of diseases.
- Personalized Medicine: Cell analysis plays a crucial role in advancing personalized medicine. By studying individual cells, researchers can identify biomarkers that are specific to certain diseases or patient populations. This information enables the development of targeted therapies and personalized treatment strategies, optimizing patient outcomes.
- Drug Discovery and Development: The cell analysis market contributes significantly to drug discovery and development. By using high-throughput screening and cell-based assays, researchers can evaluate the efficacy and toxicity of potential drug candidates. This helps in identifying promising drug candidates early in the development process, reducing costs and improving success rates.
- Advancements in Technology: The cell analysis industry benefits from continuous advancements in technology. Innovations such as automated imaging systems, flow cytometry, single-cell sequencing, and high-resolution microscopy have enhanced the accuracy, efficiency, and throughput of cell analysis techniques. These technological advancements enable researchers to generate large-scale data sets and obtain more precise insights into cellular behavior.
- Translational Research: Cell analysis facilitates translational research by bridging the gap between basic research and clinical applications. The findings from cellular studies can be translated into clinical diagnostics, prognostics, and therapeutics. This integration helps in improving patient care, developing novel treatment approaches, and accelerating the adoption of scientific discoveries into clinical practice.
- Quality Control and Safety Testing: Cell analysis techniques play a vital role in quality control and safety testing in industries such as pharmaceuticals, biotechnology, and food and beverages. These methods ensure that products meet regulatory standards, evaluate potential toxicity, and verify the absence of contaminants, ensuring consumer safety.
- Academic and Industrial Collaboration: The cell analysis market encourages collaboration between academic institutions, research organizations, and industries. This collaboration fosters knowledge exchange, accelerates innovation, and promotes interdisciplinary research, leading to advancements in both scientific understanding and practical applications
Report Link: ( Cell Analysis Market )
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/cell-analysis-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/cell-analysis.asp
English
French (Français)
Spanish (Español)
Arabic
Portuguese (Português)
Deutsch
Turkish (Türk)
Dutch (Nederlands)
Italiano
Romaian (Română)
Português (Brasil)
Russian (русский)